Csaba Bödör Selected Research

Mycosis Fungoides

7/2015

Altered microRNA expression in folliculotropic and transformed mycosis fungoides.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Csaba Bödör Research Topics

Disease

12	Neoplasms (Cancer) 12/2023 - 07/2012
8	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2023 - 01/2017
7	Lymphoma (Lymphomas) 03/2024 - 03/2011
6	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 03/2024 - 12/2008
5	Disease Progression 03/2023 - 10/2013
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 11/2006
3	Essential Thrombocythemia 04/2019 - 11/2006
3	Primary Myelofibrosis (Myelosclerosis) 04/2019 - 11/2006
2	Glioma (Gliomas) 10/2023 - 10/2022
2	Multiple Myeloma 01/2023 - 11/2018
2	Pathologic Complete Response 01/2023 - 01/2022
2	monosomy Chromosome 7 11/2022 - 06/2012
2	GATA2 Deficiency 11/2022 - 02/2016
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 01/2020
2	Leukemia 11/2021 - 01/2017
1	Brain Neoplasms (Brain Tumor) 12/2023
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 11/2023
1	Glioblastoma (Glioblastoma Multiforme) 10/2023
1	Hypertrophy 09/2023
1	Melanoma (Melanoma, Malignant) 03/2023
1	Heart Failure 01/2023
1	Hemangiosarcoma (Angiosarcoma) 01/2023
1	Interdigitating Dendritic Cell Sarcoma 01/2022
1	Pathologic Processes 01/2022
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2018
1	Bone Marrow Failure Disorders 10/2018
1	Aplastic Anemia (Anemia, Hypoplastic) 10/2018
1	Juvenile Myelomonocytic Leukemia 10/2018
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2018
1	Familial Acute Myeloid Leukemia with Mutated Cebpa 02/2016
1	Hematologic Neoplasms (Hematological Malignancy) 01/2016
1	Hairy Cell Leukemia 01/2016
1	Residual Neoplasm 01/2016
1	Mycosis Fungoides 07/2015
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 03/2013
1	Breast Neoplasms (Breast Cancer) 01/2013
1	Liver Cell Adenoma (Hepatocellular Adenoma) 07/2012
1	Hamartoma 07/2012
1	Rhabdoid Tumor (Rhabdoid Tumors) 07/2012
1	Cystadenoma 07/2012
1	Neuroblastoma 07/2012
1	Cholangiocarcinoma 07/2012
1	Hepatocellular Carcinoma (Hepatoma) 07/2012
1	Rhabdomyosarcoma 07/2012
1	Wilms Tumor (Wilm's Tumor) 07/2012
1	Hepatoblastoma 07/2012
1	Trisomy (Trisomies) 06/2011
1	Acute Liver Failure (Fulminant Hepatic Failure) 11/2007

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 11/2023 - 11/2007
5	ibrutinibIBA 01/2023 - 01/2019
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2023 - 11/2006
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 11/2006
2	Phosphotransferases (Kinase)IBA 12/2023 - 03/2013
2	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 11/2021
2	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2015
2	Formaldehyde (Formol)FDA Link 01/2022 - 06/2011
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 03/2017
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020 - 01/2020
2	Messenger RNA (mRNA)IBA 03/2011 - 05/2005
2	Cytidine DeaminaseIBA 12/2008 - 05/2005
1	Tyrosine (L-Tyrosine)FDA Link 12/2023
1	ConnectinIBA 11/2023
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2023
1	Angiotensin IIIBA 09/2023
1	AL 8810IBA 09/2023
1	venetoclaxIBA 03/2023
1	Rituximab (Mabthera)FDA Link 03/2023
1	Cell Surface ReceptorsIBA 03/2023
1	larotrectinibIBA 01/2023
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2023
1	Histones (Histone)IBA 10/2022
1	Circulating Tumor DNAIBA 01/2020
1	Phospholipase C gammaIBA 01/2020
1	CalreticulinIBA 04/2019
1	Monoclonal AntibodiesIBA 04/2019
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 10/2018
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2018
1	AntibodiesIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	Interleukin-10 (Interleukin 10)IBA 01/2017
1	Complement Receptors (Complement Receptor)IBA 01/2017
1	telomerase RNA (bTR)IBA 02/2016
1	RNA (Ribonucleic Acid)IBA 01/2016
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 02/2014
1	MethyltransferasesIBA 10/2013
1	idelalisibIBA 03/2013
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2013
1	Zinc Finger NucleasesIBA 01/2013
1	Dasatinib (BMS 354825)FDA Link 07/2012
1	PlasticsIBA 06/2012
1	ParaffinIBA 06/2011
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2011

Therapy/Procedure

15	Therapeutics 03/2024 - 10/2013
2	Stem Cell Transplantation 11/2022 - 06/2012
2	Ligation 01/2020 - 11/2018
1	Immunotherapy 10/2023
1	Drug Therapy (Chemotherapy) 01/2022
1	Transplantation 10/2018
1	Hematopoietic Stem Cell Transplantation 10/2018